Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Users Online: 404 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  
Year : 2016  |  Volume : 6  |  Issue : 4  |  Page : 249-254

Efficacy and safety of Carica papaya leaf extract in the dengue: A systematic review and meta-analysis

1 Department of Pharmacology, GMERS Medical College, Dharpur, Patan, India
2 Indian Institute of Public Health, Gandhinagar, Gujarat, India
3 Department of Pediatrics, All India Institute of Medical Science, Rishikesh, Uttrakhand, India

Correspondence Address:
Dr. Jaykaran Charan
Department of Pharmacology, GMERS Medical College, Dharpur, Patan, Gujarat
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/2229-516X.192596

Rights and Permissions

Background: Dengue is an infectious disease associated with high mortality and morbidity. Being a viral disease, there is no specific drug available for treatment. There are some reports that Carica papaya leaf extract may improve the clinical condition of dengue patients; however, to support this, at present, there is no systematically searched and synthesized evidence available. Objectives: This systematic review and meta-analysis was designed to search the available evidence related to the efficacy and safety of C. papaya leaf extract in dengue and to synthesize the evidence in meaningful form through meta-analysis so that inference can be drawn. Materials and Methods: Randomized controlled trials related to the efficacy and safety of C. papaya leaf extract in dengue were searched from PubMed, Cochrane Clinical Trial Registry and Google Scholar. The primary endpoint was mortality, and secondary endpoints were increase in platelet count, hospitalization days, and Grade 3 and 4 adverse events. Data related to primary and secondary endpoints were pooled together and analyzed by review manager (Review Manager (RevMan) Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, Denmark) software. The random effect model was used. The bias was analyzed by the Cochrane risk of bias tool. Results: Total four trials enrolling 439 subjects were included in the analysis. Of 439 subjects, data of 377 subjects were available for analysis. C. papaya leaf extract was found to be associated with increase in platelet count in the overall analysis (mean difference [MD] =20.27 [95% confidence interval (CI) 6.21–34.73; P= 0.005]) and analysis after 4th day (MD = 28.25 [95% CI 14.14–42.37; P< 0.0001]). After 48 h, there was no significant difference between C. papaya and control group (MD = 13.38 [95% CI − 7.71–34.51; P = 0.21]). There was significant decrease in hospitalization days in the C. papaya group (MD = 1.90 [95% CI 1.62–2.18; P< 0.00001]). Because of nonavailability of data in published clinical trials, mortality, and adverse events cannot be pooled. Conclusion: C. papaya leaf extract can be considered as a potential candidate for increase in platelet count in patients of dengue, however; there is need of high-quality evidence in the form of large clinical trials before a decision related to the use of such extract is made.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded940    
    Comments [Add]    
    Cited by others 10    

Recommend this journal